Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor - PubMed (original) (raw)
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor
A G Batzer et al. Mol Cell Biol. 1994 Aug.
Abstract
We analyzed the binding site(s) for Grb2 on the epidermal growth factor (EGF) receptor (EGFR), using cell lines overexpressing EGFRs containing various point and deletion mutations in the carboxy-terminal tail. Results of co-immunoprecipitation experiments suggest that phosphotyrosines Y-1068 and Y-1173 mediate the binding of Grb2 to the EGFR. Competition experiments with synthetic phosphopeptides corresponding to known autophosphorylation sites on the EGFR demonstrated that phosphopeptides containing Y-1068, and to a lesser extent Y-1086, were able to inhibit the binding of Grb2 to the EGFR, while a Y-1173 peptide did not. These findings were confirmed by using a dephosphorylation protection assay and by measuring the dissociation constants of Grb2's SH2 domain to tyrosine-phosphorylated peptides, using real-time biospecific interaction analysis (BIAcore). From these studies, we concluded that Grb2 binds directly to the EGFR at Y-1068, to a lesser extent at Y-1086, and indirectly at Y-1173. Since Grb2 also binds Shc after EGF stimulation, we investigated whether Y-1173 is a binding site for the SH2 domain of Shc on the EGFR. Both competition experiments with synthetic phosphopeptides and dephosphorylation protection analysis demonstrated that Y-1173 and Y-992 are major and minor binding sites, respectively, for Shc on the EGFR. However, other phosphorylation sites in the carboxy-terminal tail of the EGFR are able to compensate for the loss of the main binding sites for Shc. These analyses reveal a hierarchy of interactions between Grb2 and Shc with the EGFR and indicate that Grb2 can bind the tyrosine-phosphorylated EGFR directly, as well as indirectly via Shc.
Similar articles
- A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T. van der Geer P, et al. Curr Biol. 1995 Apr 1;5(4):404-12. doi: 10.1016/s0960-9822(95)00081-9. Curr Biol. 1995. PMID: 7542991 - The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
Batzer AG, Blaikie P, Nelson K, Schlessinger J, Margolis B. Batzer AG, et al. Mol Cell Biol. 1995 Aug;15(8):4403-9. doi: 10.1128/MCB.15.8.4403. Mol Cell Biol. 1995. PMID: 7542744 Free PMC article. - Internalization of the epidermal growth factor receptor: role in signalling.
Sorkin A. Sorkin A. Biochem Soc Trans. 2001 Aug;29(Pt 4):480-4. doi: 10.1042/bst0290480. Biochem Soc Trans. 2001. PMID: 11498013 Review. - Lymphocyte antigen receptor signal integration and regulation by the SHC adaptor.
Baldari CT, Telford JL. Baldari CT, et al. Biol Chem. 1999 Feb;380(2):129-34. doi: 10.1515/BC.1999.020. Biol Chem. 1999. PMID: 10195419 Review.
Cited by
- Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds.
Blanchard CE, Gomeiz AT, Avery K, Gazzah EE, Alsubaie AM, Sikaroodi M, Chiari Y, Ward C, Sanchez J, Espina V, Petricoin E, Baldelli E, Pierobon M. Blanchard CE, et al. Cell Commun Signal. 2024 Jul 26;22(1):377. doi: 10.1186/s12964-024-01742-3. Cell Commun Signal. 2024. PMID: 39061010 Free PMC article. - Structural basis of binding the unique N-terminal domain of microtubule-associated protein 2c to proteins regulating kinases of signaling pathways.
Bartošík V, Plucarová J, Laníková A, Janáčková Z, Padrta P, Jansen S, Vařečka V, Gruber T, Feller SM, Žídek L. Bartošík V, et al. J Biol Chem. 2024 Aug;300(8):107551. doi: 10.1016/j.jbc.2024.107551. Epub 2024 Jul 11. J Biol Chem. 2024. PMID: 39002671 Free PMC article. - Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance.
Tardito S, Matis S, Zocchi MR, Benelli R, Poggi A. Tardito S, et al. Int J Mol Sci. 2024 Jun 28;25(13):7131. doi: 10.3390/ijms25137131. Int J Mol Sci. 2024. PMID: 39000238 Free PMC article. Review. - Pathogenic mutations of human phosphorylation sites affect protein-protein interactions.
Rrustemi T, Meyer K, Roske Y, Uyar B, Akalin A, Imami K, Ishihama Y, Daumke O, Selbach M. Rrustemi T, et al. Nat Commun. 2024 Apr 11;15(1):3146. doi: 10.1038/s41467-024-46794-8. Nat Commun. 2024. PMID: 38605029 Free PMC article. - The impact of nitric oxide on HER family post-translational modification and downstream signaling in cancer.
O'Neill CE, Sun K, Sundararaman S, Chang JC, Glynn SA. O'Neill CE, et al. Front Physiol. 2024 Mar 27;15:1358850. doi: 10.3389/fphys.2024.1358850. eCollection 2024. Front Physiol. 2024. PMID: 38601214 Free PMC article. Review.
References
- Gene. 1988 Jul 15;67(1):31-40 - PubMed
- Cell. 1992 Aug 7;70(3):431-42 - PubMed
- Cell. 1985 Mar;40(3):619-25 - PubMed
- Mol Cell Biol. 1991 Oct;11(10):5068-78 - PubMed
- Mol Cell Biol. 1993 Mar;13(3):1449-55 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous